%0 Journal Article
%A Mizia-Stec, Katarzyna
%A Caforio, Alida L P
%A Charron, Philippe
%A Gimeno, Juan R
%A Elliott, Perry
%A Kaski, Juan Pablo
%A Maggioni, Aldo P
%A Tavazzi, Luigi
%A Rigopoulos, Angelos G
%A Laroche, Cecile
%A Frigy, Attila
%A Zachara, Elisabetta
%A Pena-Pena, Maria Luisa
%A Olusegun-Joseph, Akinsanya
%A Pinto, Yigal
%A Sala, Simone
%A Drago, Fabrizio
%A Blagova, Olga
%A Reznik, Elena
%A Tendera, Michał
%T Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology.
%D 2020
%U http://hdl.handle.net/10668/16268
%X Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke/transient ischaemic attack (TIA) in patients with cardiomyopathy. Three thousand two hundred eight consecutive adult patients with cardiomyopathy (34.9% female; median age: 55.0 years) were prospectively enrolled as part of the EURObservational Research Programme Cardiomyopathy/Myocarditis Registry. At baseline, 903 (28.2%) patients had AF (29.4% dilated, 27.5% hypertrophic, 51.5% restrictive, and 14.7% arrhythmogenic right ventricular cardiomyopathy, P  The study reveals a high prevalence and diverse distribution of AF in patients with cardiomyopathies, inadequate anticoagulation regimen, and high risk of stroke/TIA in this population.
%K Anticoagulation
%K Arrhythmogenic right ventricular cardiomyopathy
%K Atrial fibrillation
%K Dilated cardiomyopathy
%K Hypertrophic cardiomyopathy
%K Restrictive cardiomyopathy
%~